LIGAND PHARMACEUTICALS INC ROC COM

LIGAND PHARMACEUTICALS INC ROC COM is a security (CUSIP 53220K215) tracked across SEC portfolio filings. 1 institutional managers reported $16 on Form 13F as of 2026-03-31; 2 registered fund positions totaling $655 via N-PORT as of 2026-05-31.

Summary

• Issuer: LIGAND PHARMACEUTICALS INC ROC
• Class: COM
• CUSIP: 53220K215
• Asset category: EC
• 13F holders: 1
• 13F value: $16
• 13F period: 2026-03-31
• N-PORT fund positions: 2
• N-PORT value: $655
• N-PORT report: 2026-05-31

Top institutional holders (Form 13F)

Top fund holders (N-PORT)

More

• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search